Chantix, Smoking Cessation Drug, Linked to Cardiovascular Problems - NYTimes.com

Chantix, Smoking Cessation Drug, Linked to Cardiovascular Problems - NYTimes.com: "Chantix, the best-selling prescription drug for smoking cessation, was linked to an increased risk of a heart attack, stroke or other serious cardiovascular event for smokers without a history of heart disease compared with smokers who did not use the drug, according to a Canadian medical journal report released on Monday."